These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 35393604)

  • 1. Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.
    Mak A; Chan JKY
    Nat Rev Rheumatol; 2022 May; 18(5):286-300. PubMed ID: 35393604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus.
    Mohan S; Barsalou J; Bradley TJ; Slorach C; Reynolds JA; Hasni S; Thompson B; Ng L; Levy D; Silverman E; Kaplan MJ
    Arthritis Rheumatol; 2015 May; 67(8):2257-62. PubMed ID: 25891295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
    Ding X; Xiang W; He X
    Front Immunol; 2020; 11():581385. PubMed ID: 33262760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus.
    Lee PY; Li Y; Richards HB; Chan FS; Zhuang H; Narain S; Butfiloski EJ; Sobel ES; Reeves WH; Segal MS
    Arthritis Rheum; 2007 Nov; 56(11):3759-69. PubMed ID: 17968925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL/6 mice deficient in both apolipoprotein E and Fas ligand.
    Geng L; Wang S; Li X; Wang D; Chen H; Chen J; Sun Y; Chen W; Yao G; Gao X; Chen W; Shi S; Feng X; Sun L
    Curr Res Transl Med; 2018 Sep; 66(3):71-82. PubMed ID: 30108025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.
    Denny MF; Thacker S; Mehta H; Somers EC; Dodick T; Barrat FJ; McCune WJ; Kaplan MJ
    Blood; 2007 Oct; 110(8):2907-15. PubMed ID: 17638846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
    Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
    Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
    Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
    Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
    Mauro D; Nerviani A
    Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial progenitor cells in systemic lupus erythematosus.
    Patschan S; Patschan D; Potulski M; Henze E; Scholze J; Müller GA
    J Nephrol; 2013; 26(6):1065-72. PubMed ID: 24052468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.
    Spinelli FR; Barbati C; Cecarelli F; Morello F; Colasanti T; Vomero M; Massaro L; Orefice V; Alessandri C; Valesini G; Conti F
    Arthritis Res Ther; 2019 Nov; 21(1):245. PubMed ID: 31752963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus.
    Rafael-Vidal C; Martínez-Ramos S; Malvar-Fernández B; Altabás-González I; Mouriño C; Pazos-López P; Fraga-Bau A; Pego Reigosa JM; García S
    Arthritis Res Ther; 2024 Sep; 26(1):170. PubMed ID: 39342288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus.
    Castejon R; Jimenez-Ortiz C; Rosado S; Tutor-Ureta P; Mellor-Pita S; Yebra-Bango M
    Lupus; 2016 Feb; 25(2):129-36. PubMed ID: 26359174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca
    Komici K; Faris P; Negri S; Rosti V; García-Carrasco M; Mendoza-Pinto C; Berra-Romani R; Cervera R; Guerra G; Moccia F
    J Autoimmun; 2020 Aug; 112():102486. PubMed ID: 32482487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.
    Westerweel PE; Luijten RK; Hoefer IE; Koomans HA; Derksen RH; Verhaar MC
    Ann Rheum Dis; 2007 Jul; 66(7):865-70. PubMed ID: 17329307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.
    Kahlenberg JM; Thacker SG; Berthier CC; Cohen CD; Kretzler M; Kaplan MJ
    J Immunol; 2011 Dec; 187(11):6143-56. PubMed ID: 22058412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis in Systemic Lupus Erythematosus.
    Tobin R; Patel N; Tobb K; Weber B; Mehta PK; Isiadinso I
    Curr Atheroscler Rep; 2023 Nov; 25(11):819-827. PubMed ID: 37768411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
    J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramipril Improves Endothelial Function and Increases the Number of Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus.
    Oliveira ACD; Arismendi MI; Machado LSG; Sato EI
    J Clin Rheumatol; 2022 Oct; 28(7):349-353. PubMed ID: 35662232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.
    Thacker SG; Berthier CC; Mattinzoli D; Rastaldi MP; Kretzler M; Kaplan MJ
    J Immunol; 2010 Oct; 185(7):4457-69. PubMed ID: 20805419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.